Summary
The episode works through four questions that students often find difficult in the pharmacology of psychoactive drugs. It separates potency from efficacy and uses drug checking data from Victoria, British Columbia, to show why a highly potent drug of variable concentration makes the dose unknowable. It works through hypothetical examples of how the half-life governs the duration of an effect and the build-up of repeated doses, and explains why drugs with low oral bioavailability are the most sensitive to enzyme interactions, using the discovery of the grapefruit interaction in London, Ontario. It also analyses a hypothetical balanced placebo experiment and closes with a debate about what the safety ratios compiled by Robert Gable can and cannot show.